BioCentury
ARTICLE | Company News

Gensia Inc. news

April 3, 1995 7:00 AM UTC

The U.S. District Court in San Diego granted preliminary approval to an agreement to dismiss several securities class action suits brought in 1992 and 1994 against the San Diego company, its Aramed (ARAM) R&D spin-off, and several of the companies' present and former directors and officers. The claims will be dismissed without any admission of wrondoing by the defendants. Final approval comes after notification of the class members. ...